Additionally, MRCCAT1, a key lncRNA, inhibits NPR3 transcription by recruiting PRC2 to the NPR3 promoter region, therefore activating the p38-MAPK signaling pathway and promoting ccRCC metastasis (Li et al., 2017). The gene discussed is NPR3; the disease is nonpapillary renal cell carcinoma.